In this webinar, the basic principles of data normalization and how these ideas impact Seahorse XF data will be discussed.

In this webinar, Dr.Victor Darley-Usmar will introduce a new concept known as the bioenergetic-metabolite interactome, which describes how defining our bioenergetic health at the level of individual cells can now be achieved.Although we have known...

This webinar will discuss how we can selectively demolish intramural Tregs by targeting unique metabolic preference of intratumoral Tregs and how this approach can be utilized for cancer research.

This webinar assesses the Seahorse XF platform as a tool for screening mitochondrial dysfunction and presents a workflow with reference to a panel of mitochondrial toxic drugs.

The ability of cells to migrate is fundamental for many biological processes and is also the defining feature of metastatic cancers.

Using the Seahorse XF Technology, we investigated how Mtb reprogrammed the bioenergetic metabolism of the human host in vitro and ex vivo.

Presentation by Daniel Gebhard at the 4th German Pharma Tox Summit, Stuttgart, Germany, discussing workflows and case study examples of direct, real-time measurement of mitochondrial toxicity.

In this webinar, Dr.David Ferrick discusses how achieving a better understanding of immune cell metabolism has advanced cell therapies for cancer treatment.必威体育登录手机His presentation will focus on how to apply the newest XF Analyzer, the Agilent Seahorse XF...

In this webinar, Dr.Sandra Milasta, Senior Scientist of Elevatebio will discuss how metabolic pathways maintain lymphocyte survival, drive memory vs.effector function, and the implications of these findings on the development of next generation T...

Dr.David Ferrick discusses how advances in our understanding of T cell co-receptors have led to new strategies for keeping immune cells turned on in the suppressive, hostile tumor microenvironment.

In this webinar we will present an overview of the practicalities of adapting the XF Analyzer for gas flow, and the relationship between effects of drugs on ischemic injury, and their effects on metabolism.

In this webinar we will discuss the role of glutamine as a substrate to fuel mitochondrial metabolism of cancer cells, and how to genetically manipulate mitochondria to demonstrate that mitochondrial metabolism and ROS regulate cancer.

In this webinar, we will discuss how altered metabolism can impact tumorigenesis, how to investigate perturbations of cell metabolism using multidisciplinary approaches and the metabolic adaptations operating in FH-deficient cells